MANTA Vascular Closure

FDA Premarket Approval P180025 S007

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Implementation of an automated tray component packaging inspection process

DeviceMANTA Vascular Closure
Generic NameDevice, Hemostasis, Vascular
ApplicantEssential Medical, Inc.
Date Received2020-05-04
Decision Date2020-05-26
PMAP180025
SupplementS007
Product CodeMGB 
Advisory CommitteeCardiovascular
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address Essential Medical, Inc. 260 Sierra Drive suite 120 exton, PA 19341

Supplemental Filings

Supplement NumberDateSupplement Type
P180025Original Filing
S009 2021-02-10 Normal 180 Day Track
S008 2020-08-21 30-day Notice
S007 2020-05-04 30-day Notice
S006 2020-01-06 Real-time Process
S005 2019-07-23 30-day Notice
S004
S003
S002 2019-04-18 30-day Notice
S001

NIH GUDID Devices

Device IDPMASupp
00856279007079 P180025 000
00856279007062 P180025 000
20841156109957 P180025 000
20841156109933 P180025 000
20841156109926 P180025 000
20841156109902 P180025 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.